No Child Left Behind in SDHB Testing for Paragangliomas and Pheochromocytomas

被引：8
作者：
Schiffman, Joshua D. [1 ]
机构：
[1] Univ Utah, Huntsman Canc Inst, Ctr Childrens Canc Res, High Risk Pediat Canc Clin, Salt Lake City, UT 84112 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 31期
关键词：
NONPOLYPOSIS COLORECTAL-CANCER; SUCCINATE-DEHYDROGENASE; LYNCH-SYNDROME; NECK PARAGANGLIOMAS; CLINICAL-FEATURES; MUTATION CARRIERS; GENE-MUTATIONS; IMMUNOHISTOCHEMISTRY; TUMORS; HEAD;
D O I：
10.1200/JCO.2011.37.8695
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4070 / 4072
页数：4
相关论文
共 50 条
  • [41] High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations
    Heesterman, Berdine L.
    Bayley, Jean Pierre
    Tops, Carl M.
    Hes, Frederik J.
    van Brussel, Bernadette T. J.
    Corssmit, Eleonora P. M.
    Hamming, Jaap F.
    van der Mey, Andel G. L.
    Jansen, Jeroen C.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2013, 21 (04) : 469 - 470
  • [42] Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry
    C. Christofer Juhlin
    Endocrine Pathology, 2021, 32 : 228 - 244
  • [43] Screening of Mutations in Genes that Predispose to Hereditary Paragangliomas and Pheochromocytomas
    Lefebvre, S.
    Borson-Chazot, F.
    Boutry-Kryza, N.
    Wion, N.
    Schillo, F.
    Peix, J. -L.
    Brunaud, L.
    Finat, A.
    Calender, A.
    Giraud, S.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (05) : 334 - 338
  • [44] Clinical differences between small and large pheochromocytomas and paragangliomas
    Zhao, Lin
    Li, ZhiMao
    Meng, Xu
    Fan, Hua
    Zhang, ZengLei
    Zhang, ZhaoCai
    Liu, YeCheng
    Zhou, XianLiang
    Zhu, HuaDong
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [45] Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress
    Jimenez, Paola
    Tatsui, Claudio
    Jessop, Aaron
    Thosani, Sonali
    Jimenez, Camilo
    CURRENT ONCOLOGY REPORTS, 2017, 19 (12)
  • [46] Novel alternative tools for metastatic pheochromocytomas/paragangliomas prediction
    Cui, Y.
    Zhou, Y.
    Gao, Y.
    Ma, X.
    Wang, Y.
    Zhang, X.
    Zhou, T.
    Chen, S.
    Lu, L.
    Zhang, Y.
    Chang, X.
    Tong, A.
    Li, Y.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (05) : 1191 - 1203
  • [47] HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors
    Leijon, Helena
    Salmenkivi, Kaisa
    Heiskanen, Ilkka
    Hagstrom, Jaana
    Louhimo, Johanna
    Heikkila, Paivi
    Ristimaki, Ari
    Paavonen, Timo
    Metso, Saara
    Maenpaa, Hanna
    Haglund, Caj
    Arola, Johanna
    APMIS, 2016, 124 (09) : 757 - 763
  • [48] Protocol for the Examination of Specimens From Patients With Pheochromocytomas and Extra-Adrenal Paragangliomas
    Mete, Ozgur
    Tischler, Arthur S.
    de Krijger, Ronald
    McNicol, Anne Marie
    Eisenhofer, Graeme
    Pacak, Karel
    Ezzat, Shereen
    Asa, Sylvia L.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (02) : 182 - 188
  • [49] Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas
    Klein, Roger D.
    Jin, Long
    Rumilla, Kandelaria
    Young, William F., Jr.
    Lloyd, Ricardo V.
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2008, 17 (02) : 94 - 100
  • [50] Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes
    Martucci, Victoria L.
    Lorenzo, Zarina G.
    Weintraub, Michael
    del Rivero, Jaydira
    Ling, Alexander
    Merino, Maria
    Siddiqui, Minhaj
    Shuch, Brian
    Vourganti, Srinivas
    Linehan, W. Marston
    Agarwal, Piyush K.
    Pacak, Karel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (04) : 167.e13 - 167.e20
12345